{"id":4010,"date":"2025-12-10T15:47:18","date_gmt":"2025-12-10T18:47:18","guid":{"rendered":"https:\/\/desertking.com\/?p=4010"},"modified":"2025-12-10T15:47:18","modified_gmt":"2025-12-10T18:47:18","slug":"crm197-muc1-cancer-vaccine-enhanced-immune-response","status":"publish","type":"post","link":"https:\/\/desertking.com\/es\/crm197-muc1-cancer-vaccine-enhanced-immune-response\/","title":{"rendered":"Pifferi, C., et al. Design, synthesis and immunological evaluation of CRM197-based immunogens functionalized with synthetic scaffolds displaying a tumor-associated MUC1 glycopeptide. Biomater Sci, 2025 Nov 20."},"content":{"rendered":"<h2><span style=\"font-weight: 400;\">Pifferi, C., et al. Design, synthesis and immunological evaluation of CRM<\/span><span style=\"font-weight: 400;\">197<\/span><span style=\"font-weight: 400;\">-based immunogens functionalized with synthetic scaffolds displaying a tumor-associated MUC1 glycopeptide. <\/span><i><span style=\"font-weight: 400;\">Biomater Sci<\/span><\/i><span style=\"font-weight: 400;\">, 2025 Nov 20. PMID: 41263603<\/span><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">This study aims to address the challenge of developing effective vaccines against tumor-associated MUC1 (taMUC1), a glycoprotein that is overexpressed and aberrantly glycosylated in many cancers but remains poorly immunogenic. The researchers developed a semi-synthetic vaccine platform that displays taMUC1 glycopeptides on synthetic cyclic peptide scaffolds, which are then conjugated to the CRM197 carrier protein. This innovative approach seeks to enhance antigen presentation and immune recognition by preserving antigen accessibility and promoting clustered display, thereby overcoming the limitations associated with weakly immunogenic tumor antigens. The work is grounded in the need to improve cancer vaccine efficacy by optimizing antigen architecture and leveraging adjuvants such as QS-21 to stimulate robust humoral and cellular immune responses, ultimately aiming to generate better targeted immunotherapies against cancer.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The main results demonstrated that both monovalent and tetravalent CRM197-based conjugates, when formulated with the QS-21 adjuvant, elicited comparable levels of antigen-specific IgGs and activated CD4+ and CD8+ T-cell responses in mice. Importantly, the tetravalent conjugate induced enhanced recognition of native taMUC1 on MCF7 cancer cells, suggesting improved epitope accessibility and immune targeting. These findings highlight that scaffold design and antigen valency significantly influence the immunogenicity and effectiveness of the vaccine platform, with the potential to improve immune responses against weak tumor-associated antigens through optimized antigen presentation and adjuvantation strategies.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The study reports that all vaccine prototypes, including the CRM197-based conjugates formulated with QS-21, were well tolerated in the animal models. The mice showed no overt signs of distress, illness, abnormal behavior, or significant weight loss throughout the dosing regimen. Therefore, within the scope of this preclinical study, no notable side effects or adverse events were observed.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The current work is conducted in mouse models, which may not fully recapitulate human immune responses. The safety profile, immunogenic durability over time, and efficacy in humans remain to be established. Additionally, the complex synthesis and conjugation processes, although optimized for preclinical evidence, might pose manufacturing challenges for clinical translation. Proposed next steps include translating this vaccine framework into clinical studies to assess safety, immunogenicity, and efficacy in humans. Further investigation is needed to evaluate long-term immune responses, potential toxicity, and therapeutic efficacy in tumor models, as well as to optimize manufacturing protocols for potential scalability.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Click <\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/41263603\/\" rel=\"nofollow noopener\" target=\"_blank\"><span style=\"font-weight: 400;\">here <\/span><\/a><span style=\"font-weight: 400;\">to access the full scientific paper.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\t\t\t<style>\r\n\t\t\t\t#sfba_subscribe_form_719 .subscribeform1 {\r\n\t\t\t\t\twidth: 512px;\r\n\t\t\t\t\tborder: 0px solid rgba(0,0,0,0);\r\n\t\t\t\t\tfont-family: 'Verdana';\r\n\t\t\t\t\tbackground-color: #759e2c;\r\n\t\t\t\t\tbackground-image: url('');\r\n\t\t\t\t}\r\n\t\t\t\t#sfba_subscribe_form_719 #sfba-main-form-container.subscribeform1 .sfba-form-sub-heading {\r\n\t\t\t\t\tcolor: #102341;\r\n\t\t\t\t}\r\n\t\t\t\t#sfba_subscribe_form_719 #sfba-main-form-container.subscribeform1 .sfba-form-privacy-heading {\r\n\t\t\t\t\tcolor: ;\r\n\t\t\t\t}\r\n\t\t\t\t#sfba_subscribe_form_719 #sfba-main-form-container.subscribeform1 .sfba-form-heading {\r\n\t\t\t\t\tcolor: #ffffff;\r\n\t\t\t\t}\r\n\t\t\t\t#sfba_subscribe_form_719 .subscribeform1 .sfba_subscribe_form__fields .sfba-form-fields {\r\n\t\t\t\t\tborder-color: rgba(0,0,0,0);\r\n\t\t\t\t}\r\n\t\t\t\t#sfba_subscribe_form_719 .subscribeform1 .sfba-form-consent-fields-main label,\r\n\t\t\t\t#sfba_subscribe_form_719 .subscribeform1 .sfba-form-consent-fields-main {\r\n\t\t\t\t\tcolor: #ffffff;\r\n\t\t\t\t}\r\n\t\t\t\t#sfba_subscribe_form_719 .subscribeform1 #sfba-form-button {\r\n\t\t\t\t\tbackground-color: #4c6938;\r\n\t\t\t\t\tcolor: #ffffff;\r\n\t\t\t\t\tfont-size: 14px;\r\n\t\t\t\t}\r\n\t\t\t\t.subscribeform6 #sfba-form-button {\r\n\t\t\t\t\tbackground-image: url(https:\/\/desertking.com\/wp-content\/plugins\/wp-subscribe-forms-pro\/includes\/..\/images\/sent.png);\r\n\t\t\t\t}\r\n\t\t\t\tinput.sfba-form-fields::placeholder { \/ Chrome, Firefox, Opera, Safari 10.1+ \/\r\n\t\t\t\t  color: #7E7E7E;\r\n\t\t\t\t  opacity: 1; \/ Firefox \/\r\n\t\t\t\t}\r\n\t\t\t\tinput.sfba-form-fields:-ms-input-placeholder { \/ Internet Explorer 10-11 \/\r\n\t\t\t\t  color: #7E7E7E;\r\n\t\t\t\t}\r\n\t\t\t\tinput.sfba-form-fields::-ms-input-placeholder { \/ Microsoft Edge \/\r\n\t\t\t\t  color: #7E7E7E;\r\n\t\t\t\t}\r\n\t\t\t\t\r\n\t\t\t\t.sfba_thanks_container a.sfba-form-close {\r\n\t\t\t\t\twidth: 16px;\r\n\t\t\t\t\theight: 16px;\r\n\t\t\t\t\tline-height: 16px;\r\n\t\t\t\t\tposition: absolute;\r\n\t\t\t\t\ttop: 6px;\r\n\t\t\t\t\tright: 6px;\r\n\t\t\t\t\tz-index: 1;\r\n\t\t\t\t\topacity: .75;\r\n\t\t\t\t\tcolor: #ffffff;\r\n\t\t\t\t\ttext-decoration: none;\r\n\t\t\t\t\tfont-size: 36px;\r\n\t\t\t\t}\r\n\t\t\t<\/style>\r\n\t\t\t<form id=\"sfba_subscribe_form_719\" class=\"sfba_subscribe_form \" action=\"\" method=\"POST\">\r\n\t\t\t\t<div id=\"sfba-main-form-container\" class=\"sfba-main-form-container subscribeform1 sfba-attention-effect-default\">\r\n\t\t\t\t\t\t\t\t\t\t<div class=\"sfba-form-heading-subheading\">\r\n\t\t\t\t\t\t<h2 class=\"subscribeform1_heading sfba-form-heading\">Saponin Science Spotlight<\/h2>\r\n\t\t\t\t\t\t<p class=\"subscribeform1_sub_heading sfba-form-sub-heading\">Join Our Scientific Papers Newsletter<\/p>\r\n\t\t\t\t\t<\/div>\r\n\t\t\t\t\t<div class=\"sfba_subscribe_form_fields_wrap\">\r\n\t\t\t\t\t\t<div class=\"sfba_subscribe_form__fields  sfba-form-email-half\">\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<input id=\"sfba-form-name\" name=\"sfba-form-name\" class=\"sfba-form-fields sfba-form-name\" type=\"text\" value=\"\" placeholder=\"Your Name\" \/>\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<input id=\"sfba-form-email\" name=\"sfba-form-email\" class=\"sfba-form-fields sfba-form-email\" type=\"email\" value=\"\" placeholder=\"Your Email\" \/>\r\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<p id=\"sfba-consent-fields-main\" class=\"sfba-form-consent-fields-main\">\r\n\t\t\t\t\t\t\t\t\t<label>\r\n\t\t\t\t\t\t\t\t\t\t<input type=\"checkbox\" name=\"sfba-form2-consent-field\" value=\"1\" \/>\r\n\t\t\t\t\t\t\t\t\t\t<span class=\"subscribeform1_consent_txt\">I agree to receive email updates<\/span>\r\n\t\t\t\t\t\t\t\t\t<\/label>\r\n\t\t\t\t\t\t\t\t<\/p>\r\n\t\t\t\t\t\t\t\t<p class=\"sfba-conset-field-error error\" style=\"display:none !important; color:#ff0606;\">Please Select \"I agree to receive email updates\" options.<\/p>\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p class=\"sfba-email-field-error error\" style=\"display:none !important; color:#ff0606;\">Email field is required to register.<\/p>\r\n\t\t\t\t\t\t\t\t\t\t\t\t<input type=\"submit\" id=\"sfba-form-button\" class=\"sfba-form-submit-button subscribeform1_subscribe_btn\" data-form-id=\"subscribeform1\" data-rand-id=\"sfba_subscribe_form_719\" value=\"Register\" \/>\r\n\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t\t<div id=\"sfba_thanks_container\" class=\"sfba_thanks_container\" style=\"display: none;\">\r\n\t\t\t\t\t\t<a href=\"javascript:void(0);\" class=\"sfba-form-close\" data-form-id=\"sfba_subscribe_form_719\">x<\/a>\r\n\t\t\t\t\t\t<div class=\"sfba-thanks-wrap\">\r\n\t\t\t\t\t\t\t<p id=\"sfba_thanks_image\" class=\"sfba-noempty\">\r\n\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/desertking.com\/wp-content\/uploads\/2025\/03\/tick.png\" \/>\r\n\t\t\t\t\t\t\t<\/p>\r\n\t\t\t\t\t\t\t<p id=\"sfba_thanks_message\" class=\"subscribeform1_thanks_message\">You have successfully registered to our Newsletter<\/p>\r\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t<\/div>\t\r\n\t\t\t\t<\/div>\r\n\t\t\t\t<input type=\"hidden\" id=\"sfba_page_link\" class=\"sfba_page_link\" name=\"sfba-page-link\" value=\"https:\/\/desertking.com\/es\/crm197-muc1-cancer-vaccine-enhanced-immune-response\/\" \/>\r\n\t\t\t\t<input type='hidden' id='sfba_post_type_id' class=\"sfba_post_type_id\" name=\"sfba_post_type_id\" value=\"3298\" \/> \r\n\t\t\t\t\t\t\t<\/form>\r\n\t\t\t<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pifferi, C., et al. Design, synthesis and immunological evaluation of CRM197-based immunogens functionalized with synthetic scaffolds displaying a tumor-associated MUC1 glycopeptide. Biomater Sci, 2025 Nov 20. PMID: 41263603 This study aims to address the challenge of developing effective vaccines against tumor-associated MUC1 (taMUC1), a glycoprotein that is overexpressed and aberrantly glycosylated in many cancers but [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":4011,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"rs_blank_template":"","rs_page_bg_color":"","slide_template_v7":"","footnotes":""},"categories":[46],"tags":[],"class_list":["post-4010","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-texto-cientifico"],"_links":{"self":[{"href":"https:\/\/desertking.com\/es\/wp-json\/wp\/v2\/posts\/4010","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/desertking.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/desertking.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/desertking.com\/es\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/desertking.com\/es\/wp-json\/wp\/v2\/comments?post=4010"}],"version-history":[{"count":0,"href":"https:\/\/desertking.com\/es\/wp-json\/wp\/v2\/posts\/4010\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/desertking.com\/es\/wp-json\/wp\/v2\/media\/4011"}],"wp:attachment":[{"href":"https:\/\/desertking.com\/es\/wp-json\/wp\/v2\/media?parent=4010"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/desertking.com\/es\/wp-json\/wp\/v2\/categories?post=4010"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/desertking.com\/es\/wp-json\/wp\/v2\/tags?post=4010"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}